Owkin and Evotec partner to accelerate therapeutics in oncology and I&I
The companies will aim to select targets, discover and develop new therapeutics
Read More
Tag: Evotec
Human trials for world’s first AI-designed immuno-oncology drug
The drug was discovered through an AI-design platform within just eight months of project initiation
Read More
Evotec links with Takeda
The companies aim to establish five new drug discovery programmes
Read More
£13m Oxford partnership to accelerate drug innovations
Oxford University, Oxford University Innovation (OUI), Oxford Sciences Innovation (OSI) and Evotec have formed a new public-private alliance to help progress the development of new medicines stemming from Oxford research.
Read More
Bayer and Evotec form kidney disease research pact
Bayer and Evotec have signed a five-year, multi-target research pact to develop clinical candidates for the treatment of chronic kidney diseases.
Read More
- Francis Crick, UCL and AZ identify why treatment fails for NSCLC patients
- Royal Marsden launches first UK genome testing facility to improve testing for cancer
- Sysmex receives Longitude Prize on AMR for antimicrobial testing system
- LifeArc funds new projects to address and prevent global threat of dengue fever
- New study reveals how brain cell communication is linked to Alzheimer’s disease
